Login / Signup

ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy.

Masoud SotoudehRamin ShakeriSanford M DawseyBahareh SharififardNaser AhmadbeigiMahmood Naderi
Published in: Cancer immunology, immunotherapy : CII (2019)
Our findings suggest that ANTXR1 is a promising candidate for preclinical and clinical evaluation for gastric adenocarcinoma immunotherapy.
Keyphrases
  • clinical evaluation
  • squamous cell carcinoma
  • locally advanced
  • cell proliferation
  • transcription factor
  • cell therapy
  • amino acid
  • stem cells
  • rectal cancer
  • radiation therapy
  • bone marrow